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Introduction of Problem 
 Malignant hyperthermia (MH) is a rare, potentially lethal skeletal muscle syndrome that 
occurs after genetically susceptible individuals are exposed to volatile anesthetics or 
succinylcholine (Diu & Mancuso, 2012). The volatile anesthetics sevoflurane, desflurane, and 
isoflurane are the most commonly used agents for the maintenance of anesthesia in the operating 
room (Ebert & Lindenbaum, 2013). Succinylcholine, one of the most popular neuromuscular 
blocking agents, is the only ultra-rapid onset duration relaxant currently available (Donati, 2013). 
A response plan, staff preparation and education, and prompt recognition of the signs of MH are 
essential to prevent death and severe complications related to MH (MHAUS, 2017c). The 
purpose of this project was to develop a comprehensive computer-based learning (CBL) module 
about MH for a tertiary care center in central IL and evaluate the effectiveness of the CBL by 
assessing perioperative staff knowledge. 
Literature Review 
 The symptoms of MH have been reported since the 1900’s and the incidence rose with 
increasing frequency until the late 1960’s (Britt, 1987). Malignant hyperthermia was named by 
Dr. Gordon, a professor of anesthesia at the University of Toronto, in 1966 (Britt, 1987). After 
the mid 1960s, the death rate from MH slowly declined due to increased awareness, increased 
research, and advances in patient monitoring. In 1975 dantrolene was successfully used to treat 
MH in Landrace pigs (Britt, 1987).   
 RYR1 and CACNA1S are the two main gene mutations associated with this inherited 
disorder. RYR1, the most important gene, is an ion channel in the sarcoplasmic reticulum of 
skeletal muscle that releases calcium for muscle contraction to occur (Rosenberg et al., 2015). In 
MH, after exposure to triggering agents, the RYR1 ion channel remains open causing an 
uninhibited release of calcium and persistent muscle contraction (Schneiderbanger et al., 2014). 
The results are increased temperature, increased CO2 production, increased oxygen 
consumption, and the release of potassium and creatinine kinase as the membrane integrity of the 
cells fails (Hopkins, 2007). 
 The first step to prepare for MH starts with developing a response plan that includes 
education and training (Dirksen, Van Wicklin, Mashman, Niederer, & Merritt, 2013). Providing 
annual MH education with mock drills and completing a comprehensive preoperative assessment 
on every patient is necessary in order to prevent an MH reaction (Rosenberg, Pollock, 
Schiemann, Bulger, & Stowell, 2015). Then the operating room (OR) must be prepared, and an 
anesthesia plan developed which is free of MH triggering agents once a patient is identified as 
MH susceptible.  Preparing the OR entails preparing the anesthesia machine per manufacturer’s 
instructions, removing all volatile anesthetics from machine, and considering the use of activated 
charcoal filters (MHAUS, 2017f). 
 The clinical signs of MH crisis include an increase in heart rate, body metabolism, CO2 
production, muscle rigidity, and fever (MHAUS, 2017c). Treatment is often delayed because 
these symptoms are nonspecific and can be seen in a wide variety of conditions like sepsis, 
malignant neuroleptic syndrome, serotonergic syndrome, thyroid storm, hyperthyroidism, and 
pheochromocytoma (Diu & Mancuso, 2012). Once MH is recognized all triggering agents should 
be stopped, and the MH rapid response plan should be initiated (MHAUS, 2017a). Dantrolene is 
the only antidote and should be given as soon as possible to reverse the effects of MH (Diu & 
Mancuso, 2012). Dantrium/Revonto and Ryanodex are the two forms of dantrolene sodium 
available to treat MH (MHAUS, 2017a). After administration of dantrolene, symptomatic 
treatment for the hyperthermia, acidosis, rhabdomyolysis, myoglobinemia, and hyperkalemia 
may be necessary. 
 Most of the time the diagnosis of MH is made by the clinical signs and symptoms that 
present after receiving triggering agents, like succinylcholine and volatile inhalational 
anesthetics (Dui & Mancuso, 2012). The caffeine halothane contracture test (CHCT), developed 
in 1970, is the gold standard for diagnosing MH and to determine a person’s susceptibility to the 
disease (Larach, Brandom, Allen, Gronert, & Lehman, 2015).  Another way to screen for MH is 
a blood test that looks for one of the 31 variants of RYR1 mutations (Schneiderbanger et al., 
2014).  Although this test can be nonspecific, it is an important tool, especially with patients that 
have a family history of malignant hyperthermia (Schneiderbanger et al., 2014). 
Project Methods 
 The goals for this project were to develop a comprehensive computer-based learning 
module about MH for a tertiary care center in central Illinois and evaluate the effectiveness of 
the CBL on perioperative staff knowledge. This CBL module provided continuing education to 
staff on the triggering agents, signs and symptoms, and treatment for MH. The CBL module also 
allowed the tertiary care center to be in accordance with CMS guideline 482.25(b)(8). The long-
term goal is that this CBL module will be able to provide annual continuing education. 
 The CBL was assigned to perioperative staff members as a self-study educational 
program and was available for one month. All nurses who care for patients in the operating room 
or in a recovery area, such as ICU and OB, were included in the project. The project’s sample 
included 124 nurses and anesthesia providers from the host facility that took the CBL in the 
allotted one-month time frame. 
Southern Illinois University Edwardsville’s Institutional Review Board (IRB) evaluated 
this project and considered it IRB exempt. After approval from IRB, the project was then 
evaluated and approved by St. John’s Hospital Research Review Committee. The two human 
subject’s risks are loss of confidentiality and time inconvenience. 
Evaluation 
 This project was a nonexperimental and included a pretest and posttest to assess the 
effectiveness of the CBL at increasing perioperative staff knowledge on MH. The outcomes were 
measured via the pretest and posttest questionnaire consisting of 10 questions. The results were 
analyzed by the project owner in order to maintain anonymity of participants. The CBL was 
made available to anesthesia providers and perioperative registered nurses through the hospitals 
online education program called HealthStream.  
 The pretest and post-test score data was not matched; therefore, the author was unable to 
analyze knowledge gained per individual or per question. So, it is unknown if specific 
knowledge was obtained after participants completed the CBL. However, the average post-test 
score was 93% compared to the average pretest score of 70%. These results suggest this project 
was effective in increasing perioperative staff knowledge on MH.  
 The CBL power point took multiple months, a lot longer than anticipated, to complete. 
The power point was edited and reviewed multiple times by various people to ensure 
appropriateness for the specific audience. Revisions were completed by email and by 
coordinating meetings with the author, team leader, and external stakeholder. The author found it 
difficult at times to coordinate everyone involved to meet in person to review the project.  Once 
the power point was complete, the CBL was submitted to the education coordinator at the host 
facility for implementation. One unforeseen circumstance was that the coordinator decided to 
leave the CBL open for three months instead of the one month that was originally discussed. In 
hindsight, the author was unrealistic in thinking that all staff would be able to take the CBL in 
the original allotted time frame of one month. 
Impact on Practice 
 The increased knowledge from the CBL will help decrease morbidity and mortality 
should a MH reaction occur. The long-term impact is that this CBL module will be able to 
provide annual continuing education to all healthcare professionals in departments that use and 
recover patients exposed to MH triggering agents. The long-term goal is to make mortality from 
a MH reaction a “never event.” This project could easily be replicated at any facility that needs 
continuing education on MH. In the future, the CBL module should be a mandatory educational 
module that has to be completed by a predetermined deadline. Having the module open for three 
to six months would provide adequate time for all staff to complete.  
Conclusion 
 Succinylcholine and volatile inhalational anesthetics continue to play a large role in 
anesthesia care. Although these medications have great benefits, they have very detrimental side 
effects in MH susceptible patients. Continuing education of perioperative staff is an integral part 
of emergency preparedness. This project evaluated the benefits of using a CBL module to meet 
the educational needs of perioperative staff. The results of this project suggested the CBL was 
effective in increasing perioperative staff knowledge on MH. Future efforts should focus on 
improving mock drills related to preparing the OR room for a MH patient and responding to a 
MH reaction.  
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